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Available online 25 March 2016Conduction abnormalities are frequently associatedwith cardiac disease, though themechanisms underlying the
commonly associated increases in PQ interval are not known. This study uses a chronic left ventricular (LV) apex
myocardial infarction (MI) model in the rabbit to create signiﬁcant left ventricular dysfunction (LVD) 8 weeks
post-MI. In vivo studies established that the PQ interval increases by approximately 7 ms (10%) with no signiﬁ-
cant change in average heart rate. Optical mapping of isolated Langendorff perfused rabbit hearts recapitulated
this result: time to earliest activation of the LV was increased by 14 ms (16%) in the LVD group. Intra-atrial and
LV transmural conduction times were not altered in the LVD group. Isolated AVN preparations from the LVD
group demonstrated a signiﬁcantly longer conduction time (by approximately 20 ms) between atrial and His
electrograms than sham controls across a range of pacing cycle lengths. This difference was accompanied by in-
creased effective refractory period and Wenckebach cycle length, suggesting signiﬁcantly altered AVN electro-
physiology post-MI. The AVN origin of abnormality was further highlighted by optical mapping of the isolated
AVN. Immunohistochemistry of AVN preparations revealed increased ﬁbrosis and gap junction protein
(connexin43 and 40) remodelling in the AVN of LVD animals compared to sham. A signiﬁcant increase in
myocyte–non-myocyte connexin co-localization was also observed after LVD. These changes may increase the
electrotonic load experienced by AVNmuscle cells and contribute to slowed conduction velocity within the AVN.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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The prognosis in chronic heart failure (CHF) is affected by conduc-
tion abnormalities in both the atrio-ventricular node (AVN) and the
His-Purkinje system in approximately 50% of patients [1–5]. Atrio-
ventricular and intra-ventricular conduction changes can produce ad-
verse haemodynamic effects via their impact on left ventricular (LV)/
right ventricular (RV) synchrony and ventricular contraction-
relaxation sequence. Slower atrio-ventricular conduction manifests it-
self on the surface electrocardiogram (ECG) via a prolonged PR interval.
This leads to delayed ventricular activation which may be sufﬁcient to
cause pre-systolic mitral regurgitation, reducing LV preload and,-nodal; CHF, chronic heart fail-
N effective refractory period;
e; LVD, left ventricular dysfunc-
ernight; RV, right ventricle; RT,
.
. This is an open access article underhence, output. Multisite biventricular pacing techniques (also known
as cardiac resynchronisation therapy) improve cardiac hemodynamic
function by correcting LV and RV activation times [6–8]. Further im-
provements in systolic function can be achieved by optimisation of pre-
load by correct timing of atrio-ventricular delay [2,9,10]. The causes and
mechanisms of abnormal conduction are not known. In particular,
whether a speciﬁc site in the conduction system is involved, and
whether the effect is a direct or indirect consequence of a pathological
change, are open questions. That said, a recent publication reported
both structural and molecular changes within the AVN of a rabbit
model of cardiac hypertrophy [11], suggesting that this tissue region
may be causally involved.
Physiological conduction in the AVN is already slow, compared to
atrial and ventricular myocardium, due to distinct electrical properties
of AVN tissue, including signiﬁcantly different expression levels of a
range of ion channels, including connexins [12]. The mammalian heart
contains three main connexin isoforms: connexin43 (Cx43),
connexin40 (Cx40) and connexin45 (Cx45). There is heterogeneous ex-
pression of all three isoforms within the tissue of the Triangle of Koch
[13]. The most abundant cardiac connexin, Cx43, has major roles inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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shows relatively low expression within the compact AVN, but is ob-
served in the transitional zones of the atrio-nodal (AN) and nodo-
Hisian (NH) regions. The posterior nodal extension has the lowest
Cx43 mRNA and the most abundant HCN4 mRNA levels, in keeping
with its low conduction velocity and secondary pacemaker activity
[14]. In contrast, the low-conductivity Cx45 has been shown to be abun-
dant in the compact node, and both Cx40 and Cx45 have been reported
in the NH region [15–17].
The mechanisms underlying abnormal delays in atrio-ventricular
conduction in CHF are not fully understood. This study therefore aims
to assess atrio-ventricular conduction delay in a rabbit model of left
ventricular dysfunction (LVD) due to apical myocardial infarction
(MI), and to investigate possible mechanisms underlying this delay.
Our results indicate that the signiﬁcantly longer PQ interval, observed
in this rabbit model of LVD, is due to abnormally slow conduction
through the compact AVN. The increase in conduction time is associated
with ﬁbrosis, higher non-myocyte content and altered expression of
connexins in the AVN, possibly including hetero-typic cell coupling, as
part of the structural remodelling following MI.
2. Methods
2.1. Animal model
Procedures were undertaken in accordance with the United
Kingdom Animals (Scientiﬁc Procedures) Act of 1986 and conform to
the Guide for the Care and Use of Laboratory Animals published by the
US National Institutes of Health (NIH Publication No. 85–23, revised
1996). A well-characterised model of MI, induced by coronary artery li-
gation, was used [18–24]. In short, adult male New Zealand White rab-
bits (2.5–3.0 kg) were given premedication with 0.4 mL/kg
intramuscular Hypnorm (fentanyl citrate, 0.315 mg/mL: ﬂuanisone
10 mg/mL, Janssen Pharmaceuticals). Anaesthesia was induced with
0.25–0.5 mg/kg midazolam (Hypnovel, Roche) given via an indwelling
cannula in themarginal ear vein. Rabbits were intubated and ventilated
using a Harvard small animal ventilator with a 1:1 mixture of nitrous
oxide and oxygen containing 1% halothane at a tidal volume of 50 mL
and a frequency of 40 min−1. Preoperative antibiotic prophylaxis was
givenwith 1mLAmﬁpen (ampicillin 100mg/mL,Mycofarm UK Ltd) in-
tramuscularly. A left thoracotomywas performed through the 4th inter-
costal space. Quinidine hydrochloride (10 mg/kg; Sigma
Pharmaceuticals), a class IA antiarrhythmic (potassium channel
blocker) was administered intravenously prior to coronary artery liga-
tion to reduce the incidence of ventricular ﬁbrillation. The marginal
branch of the left circumﬂex coronary artery, which supplies most of
the LV free wall, was ligated halfway between the atrio-ventricular
groove and the cardiac apex to produce an ischaemic area of 30–40%
of the LV. As there is relatively little collateral circulation in the rabbit,
a relatively uniform apical MI was produced transmurally, occupying
on average 14% of the total endocardial and epicardial surfaces of the
LV (Fig 1A(i)) [18]. Sham controls did not undergo coronary artery liga-
tion, but were subjected to all other interventions.
2.2. Characterisation of the rabbit model of LVD
Rabbits were sedated with 0.3 mg/kg Hypnorm prior to echocardi-
ography and ECG. Echocardiographic assessment of LV end-diastolic di-
mension and systolic function was performed at 7 weeks post coronary
artery ligation or shamoperation, using a 5MHzpaediatric probewith a
Toshiba sonograph (Sonolayer 100). The ECG was measured to deter-
mine RR and PQ intervals, and QS and QT durations in the intact animal,
and to identify any effect of LVD on these parameters. PQ and QS inter-
valswere reported instead of PR in an attempt to assess the contribution
of ventricular conduction time separately from atrial and AVN conduc-
tion. To record high quality ECG signals, three electrodes werepositioned subcutaneously, and the ECG recorded from lead II. Increased
inducibility of arrhythmias and lowered ventricular ﬁbrillation thresh-
old were further assessed after organ isolation, ex vivo, 8 weeks after
the initial surgery [18].
This study describes investigations both in vivo and in vitro. Three
distinct in vitro studies were performed: (i) optical measurements on
isolated whole hearts (8 sham and 8 LVD preparations); (ii) extracellu-
lar electrodemeasurements on isolatedAVNpreparations (14 shamand
14 LVD); (iii) optical measurements on isolated AVN preparations (4
sham and 4 LVD). In a separate set of experiments, ECG measurements
were made on sham and LVD rabbit groups as described above (8 sham
and 8 LVD animals). Accumulatedmortality statistics, excludingmortal-
ity associated with the operative procedure, were collected over ap-
proximately 20 years of studies using the rabbit MI model (499 LVD
and 303 sham procedures).
2.3. Whole heart optical mapping studies
Eight weeks after surgery, rabbits (8 LVD, 8 sham controls) were
sacriﬁced with an intravenous injection of 0.5 mL/kg Euthatal (sodium
pentobarbitone 200mg/kg, RhoneMerieux), mixedwith 500 IU of hep-
arin. Hearts were rapidly excised and Langendorff-perfused with oxy-
genated Tyrode's solution (containing in mmol/L: NaCl 93, NaHCO3 20,
Na2HPO4 1.0, MgSO4 1.0, KCl 5.0, CaCl2 1.8, Na-acetate 20, and glucose
20; equilibrated with 95% O2/5% CO2, pH 7.4.) at 37 °C and at constant
rate of 40mL/min using a Gilson Minipuls 3 peristaltic pump. Perfusion
pressure was monitored with a transducer in the aortic cannula. A pair
of platinum stimulation electrodes was placed in the low right atrium.
Hearts were loaded with a bolus injection (200 μL injected into the per-
fusate over 30 s, i.e. diluted in 20 mL of saline) of the voltage sensitive
dye RH237 (Molecular Probes, OR USA) dissolved in DMSO
(1 mg/mL). For optical mapping recordings, hearts were placed in a
custom-built chamber which allowed control of bathing solution tem-
perature and recording of global ECG via wall-ﬁxed electrodes (Fig.
2A). The anterior surface of the heart was illuminated by 535 ±
25 nm light (interference ﬁlter, Comar Instruments Ltd, UK) from four
100 W tungsten-halogen lamps. Light emitted from the heart was col-
lected using a camera lens (Nikon 85 mm, NA 1.4), passed through a
695 nm long-pass ﬁlter (Omega Optical Inc, USA) and focused onto a
16 × 16 photodiode array (C4675-102, Hamamatsu Photonics UK Ltd).
Images were collected at 1 kHz from an area of 15 × 15 mm, saved to
computer disk, and analyzed using custom software following applica-
tion of a Gaussian spatial ﬁlter (radius 2 pixels) in accordance with
the principles set out in Mironov et al. [25]. Artefacts in electric record-
ings, caused by motion, were reduced with 3 μmol/L cytochalasin-D
(Sigma Aldrich, UK), which we previously found to have no signiﬁcant
effects on cardiac activation parameters in rabbits over the range of
stimulus frequencies used in this study [26].
Isochronal maps of activation time were constructed, and conduc-
tion velocity was derived. The range of activation times in a given
heart under speciﬁc pacing conditions was deﬁned as the difference in
timing between the earliest and latest action potential upstroke re-
corded by the photodiode array.
Transmural conduction through the LV free wall was assessed by
pacing from the ventricular endocardium via a plunge bipolar electrode
and monitoring earliest LV epicardial activation using optical mapping.
LV longitudinal conduction velocity was assessed by pacing from the
LV epicardium and monitoring optical signals at a 5 mm radius from
the activation point.
2.4. Isolated AVN preparation functional studies
In a separate set of experiments, isolated AVN preparations (14
sham and 14 LVD) were prepared by the removal of all ventricular tis-
sue, followed by an incision around the crest of the right atrial append-
age which, when folded open, exposed the endocardial surface of the
Fig. 1. In vivo parameters from the rabbit model of LVD. A: (i) Photograph of the Langendorff perfused rabbit heart showing the apical MI scar. (ii) Kaplan-Meier plot of survival in LVD
(ligation) versus sham showing increased mortality in LVD. p= 0.0018, data accumulated over several studies. B: Graphs of LV ejection fraction (expressed as a percentage), LV end-
diastolic dimension (in mm) and left atrial dimension (in mm). Results expressed as mean ± SEM; 8 sham/8 LVD animals. C: (i) Examples of surface ECG recordings in vivo. Scale bar:
250 ms. (ii–v) Graph of RR, PQ, QS and QT intervals (in ms). Results expressed as mean ± SEM; n= 8 sham/n= 8 LVD.
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moved, leaving a section of tissue containing the Triangle of Koch, the
Crista terminalis, and the right atrial appendage (Fig. 3A). The sinus
node was left intact. This preparation was pinned onto a Sylgard plate,
carefully avoiding excess deformation, and superfusedwith oxygenated
Tyrode's solution (40 mL/min, 37 °C). A bipolar silver wire stimulating
electrodewas positioned on the endocardiumat the right atrial append-
age near the sinus node. The spontaneous sinus cycle length was re-
corded in every experiment. Thereafter, the atrium was paced using
2 ms voltage pulses with amplitude of twice the threshold. Two silver
wire bipolar extracellular recording electrodes monitored surface elec-
trograms from the low inter-atrial septum and the His bundle region;the inter-electrode distance was ﬁxed at 14 mm. Electrograms were
high pass (40 Hz) ﬁltered by the MAP ampliﬁer before digitization.
Rate-dependent properties of the AVNwere determined by standard
pacing protocols. The interval between late atrial activation and His
bundle activation (AH interval) and Wenckebach cycle length (i.e.
cycle length at which atrio-ventricular block occurred) were derived
using 16 stimuli at the basic cycle length of 300 ms followed by a 1 s
pause, with the cycle length decrementing by 5 ms intervals after each
pause. The atrial effective refractory period (ERPA) was deﬁned as the
longest interval of a test sino-atrial node stimulus pulse (S1S2 interval)
that failed to elicit a corresponding atrial electrogram (A2 response),
and was determined using a protocol that consisted of 16 beats at the
Fig. 2.Optical measurements of epicardial activation time. A: Schematic diagramof the opticalmapping apparatus (CCD – charged coupled device). B: Examples of optically derived action
potentials at 3 points on the surface of the left ventricle. Traces a, b, and c originate from sham controls. Traces a, b and c originate from the LVDmodel. Timing is measured relative to the
right atrial stimulus artefact (red vertical line). C: Isochronal maps of epicardial activation time relative to right atrial stimulus in sham and LVD. Photographs and schematic drawing
illustrate the area optically imaged (LV). Epicardial activation time (in [ms]) shown on the right of the isochronal maps. Isochrones show activation times early (red) to late (blue). D:
Graph of the time to earliest epicardial activation from right atrial pacing against pacing cycle length (in ms). Mean ± SEM, n= 8 sham, n= 8 LVD preparations. *p b 0.05.
57A.M. Nisbet et al. / Journal of Molecular and Cellular Cardiology 94 (2016) 54–64basic pacing cycle length (PCL) followed by one premature beat
followed by a 1 s pause. The premature beat coupling interval was
decremented by 5 ms steps until atrial refractoriness occurred. The
AVN ERP (ERPAVN) is deﬁned as the longest interval for a test atrial stim-
ulus (A1A2 interval) that failed to elicit a test His bundle response (H2
response). The AVN functional refractory period (FRPAVN) is deﬁned as
the shortest interval between His electrogram from the standard stimu-
lus and the His electrogram from the test stimulus (H1H2 interval)achieved by premature stimulation. These protocols allow atrio-
ventricular conduction and refractoriness curves to be constructed,
from which parameters of AVN function can be derived.
The sequence of activation through the AVN in the isolated AVN
preparationwas additionally studied in 4 shamand 4 LVDAVNprepara-
tions using optical mapping. For this, excised hearts were ﬁrst loaded
with RH237 as described above. The AVN was then isolated (prepared
as described above) and mounted in a custom-made chamber to allow
Fig. 3. Electrical characteristics of the isolated AVN (i). A: Photograph of the isolated AVN preparation. Anatomical landmarks are annotated. (IVC – inferior vena cava; FO – fossa ovalis;
CrT – Crista terminalis; tT – tendon of Todaro; CS – coronary sinus; TrV – tricuspid valve; His –His bundle recording site; AVN – compact AVnodal region). B: (i) Surface electrograms from
the isolated AVN preparation showing how the time between atrial and His bundle electrograms (A1H1 time) are derived bymeasurement of the interval between the onset of the atrial
signal to the onset of the corresponding His bundle electrogram. (ii) Atrial and His bundle electrograms demonstrating progressive prolongation of the A1H1 interval and then conduction
block, i.e.Wenckebach conduction block. C: (i) Graph of A1H1 intervals against pacing cycle length (inms) in sham and LVD animals. (ii) Wenckebach cycle length (in ms). Mean± SEM,
n= 14 sham, n= 14 LVD preparations.
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face electrograms and optically derived action potentials using a Red-
shirt Imaging (USA) CCD array. The image of the AVN was focused
onto the array such that an area of (14.5 × 14.5) mm2 at a spatial reso-
lution of 40 × 40 pixels (3 kHz frame rate) was imaged. The preparation
was paced using the protocols described above.
2.5. Connexin expression and distribution and ﬁbrosis quantiﬁcation in iso-
lated AVN preparations
Following functional studies, isolatedAVNpreparations (7 sham and
7 LVD) were embedded ﬂat in Tissue-Tek (VWR International Ltd) and
rapidly frozen in liquid nitrogen following the protocol described previ-
ously [27]. Cryosections (16 μm)were cut in the plane of the AVN prep-
aration, collected on SuperFrost slides (Menzel-Glaser, Germany) andstored at −80 °C until use. For immunolabelling [28], cryosections
were ﬁxed in cold acetone (10 min), washed with phosphate buffered
saline (PBS), and blocked for 1 h at room temperature (RT) in 1% bovine
serum albumin in PBS containing 0.1% TritonX-100. Gap junction pro-
teins Cx40 and Cx43 were labelled using goat Cx40 or Cx43 antibodies
(Santa Cruz Biotechnology; 1:200, overnight (O/N) at 4 °C), followed
by the secondary donkey anti-goat Alexa488 (1:500, 2 h RT; Molecular
Probes). Myocyteswere labelledwith amouse anti-myomesin antibody
(clone B4; kindly supplied by Dr H.M. Eppenberger, ETH Zürich,
Switzerland; 1:100, O/N at 4 °C), followed by donkey anti-mouse CY3
(1:400, 2 h RT; Jackson Immuno Research Laboratories). Non-
myocytes were identiﬁed using a mouse monoclonal anti-vimentin an-
tibody (clone V9, Sigma Aldrich; 1:1000, 2 h RT) pre-conjugated with
Alexa647 using aMolecular Probes' Zenon immunolabelling kit (Molec-
ular Probes). The mouse monoclonal anti-neuroﬁlament 160 antibody
59A.M. Nisbet et al. / Journal of Molecular and Cellular Cardiology 94 (2016) 54–64(NF160; Chemicon; 1:1000, O/N at 4 °C) was used to identify the com-
pact AVN region. All immuno-labelled cryosections were mounted in
CitiFluor antifade medium (Agar Scientiﬁc, UK), and imaged with a
TCS-SP2 confocal laser-scanning microscope (Leica Microsystems,
Germany) using 488 nm excitation and 500–535 nm emission for
Alexa488 labelling, 543 nm excitation and 555–630 nm emission for
CY3 labelling, and 633 nm excitation and 650–750 nm emission for
Alexa647 labelling. Single optical slices or z-series were recorded and
images were combined to reveal localization of connexins to myocytes
and non-myocytes.
For connexin quantiﬁcation, single optical slice images showing
Cx40 or Cx43 immunolabelling, together with myocyte and non-
myocyte immunolabelling, were quantitatively analyzed using ImageJ
(http://rsb.info.nih.gov/ij/). Co-localization of connexin ﬂuorescence
spots with cell labelling (myocytes or non-myocytes) was used to iden-
tify cell-type speciﬁc expression levels. Connexin density is stated as
(i) area of connexin-related ﬂuorescence per total tissue area, (ii) area
of connexin-related ﬂuorescence per cell-type relative to total scanned
tissue area, and (iii) percentage of connexin expressed by myocytes
and non-myocytes relative to total connexin area.
Fibrosis was detected using picrosirius red staining. Brieﬂy, cryosec-
tions were ﬁxed in formol calcium (5 min), washed in tap water, incu-
bated in picrosirius red (3 min at RT), rinsed in absolute alcohol,
cleared and mounted in DPX. Stained cryosections were imaged with
a Zeiss Axioskope equipped with a Nikon DMX1200F digital camera. Fi-
brosis was quantiﬁed as percentage area of picrosirius red per total tis-
sue area.
2.6. Statistical analysis
Data are expressed as mean ± SEM. Statistical analyses were per-
formed using Student's t-test or analysis of variance. The criterion for
statistical signiﬁcance was p b 0.05.
3. Results
3.1. Characteristics of LVD in the rabbit model of heart failure
Coronary ligated rabbits showed signiﬁcant haemodynamic dys-
function, including increased LV end-diastolic dimensions and de-
creased ejection fraction compared to sham-operated controls (Fig.
1B). The surgical model was also associatedwith signiﬁcant latemortal-
ity as illustrated by the Kaplan Meier graph (Fig. 1A(ii); p = 0.0018)
based on data accumulated over a series of studies from our laboratory
[21,22,26,29–33].
Fig. 1C shows representative surface ECG recordings from sham con-
trol and LVD animals. Therewas signiﬁcant prolongation of the PQ inter-
val in LVD animals, compared to controls (Sham 72.5 ± 0.3 ms; LVD
79.4 ± 1.2 ms, n = 8 p b 0.05), but no signiﬁcant difference in the
other ECG parameters (RR interval: 339.2 ± 9.7 ms vs. 343.1 ±
13.5 ms, p N 0.05; QS interval: 44.5 ± 0.7 ms vs. 46.0 ± 2.5 ms,
p N 0.05) or QT interval 234.1 ± 6.6 ms vs. 246.0 ± 8.5 ms, p N 0.05).
3.2. Optical measurements of epicardial activation time in the intact heart
Epicardial activation during atrial pacing in sham and LVD
Langendorff-perfused rabbit hearts is shown in Fig. 2. Photographs of
the LV epicardial surface with corresponding isochronal maps of activa-
tion are illustrated in Fig. 2C. Sample optical action potentials measured
at 3 points on the epicardial surface of sham and LVD hearts are shown
in Fig. 2B. These signals were used to examine the time and pattern of
epicardial activation. As indicated in Fig. 2C, the time for earliest LV ac-
tivation was delayed in LVD hearts, compared to the sham group. Dur-
ing atrial pacing at a cycle length of 250 ms, the interval between right
atrial stimulation and ﬁrst LV epicardial activation was 14 ± 3 ms
(16 ± 2%) greater in LVD hearts than in sham. Fig. 2D shows that thiseffect was rate dependent, with higher conduction delays at lower pac-
ing cycle length.
Importantly, no increase in intra-atrial, LV transmural or LV epicar-
dial conduction time was observed in LVD hearts (e.g. intra-atrial
time: 18.8 ± 0.7 ms in LVD vs. 17.9 ± 0.8 ms sham, n = 8 each,
p N 0.5; transmural time: 14.2 ± 2.2 ms in LVD vs. 14.5 ± 3.5 ms in
sham, n = 8 each, p N 0.5), suggesting that the delay in LV activation
was not due to intra-atrial or intra-ventricular conduction slowing.
Therefore the increased time delay between atrial stimulation and the
arrival of excitation at the LV epicardial surface in LVD is likely to result
from slowed conduction inside the AVN.
3.3. Conduction slowing in isolated AVN preparations measured using ex-
tracellular electrodes
The effect of LVD on conduction inside the AVN was studied in a se-
ries of 14 shamand14 LVD isolated AVNpreparations. Fig. 3A shows the
isolated AVN with anatomical landmarks annotated. Surface right atrial
and His bundle electrograms are also shown (Fig. 3B). There was no sig-
niﬁcant difference in the spontaneous sinus cycle length between LVD
and sham animals (LVD: 373.1 ± 23.2 ms, Sham: 378.1 ± 13.6 ms,
n = 14 each; p N 0.5), which is in keeping with the in vivo data above
(Fig. 1B(ii)). When the mean atrio-Hisian (A1H1) interval for each cor-
responding S1S1 interval was plotted, the value of the A1H1 interval
was larger in LVD at all S1S1 intervals, resulting in an upward shift of
the atrio-ventricular conduction curve, compared to sham (Fig. 3C(i)).
Furthermore a signiﬁcant prolongation of theWenckebach cycle length
was observed in LVD animals, compared to sham controls (Fig. 3C(ii)).
Thus, consistent with the results obtained with intact animals and
Langendorff-perfused hearts, LVD is associated with slowed conduction
in the isolated AVN.
Effects of LVD on ERPAVN and FRPAVN, as well as on ERPA, were de-
rived using the pacing protocol described in the Methods. Results are
shown in Fig. 4. ERPA was not signiﬁcantly altered in the LVD group
compared to sham controls. However, there was a signiﬁcant prolonga-
tion in ERPAVN and FRPAVN in LVD hearts, compared to sham controls.
In keepingwith previous studies [34–36], we observed the presence
of dual pathway AVN physiology in roughly a quarter of animals, based
on the presence of discontinuity of the atrio-ventricular conduction
curve, and functionally deﬁned as an abrupt increase in the A2H2 inter-
val of ≥20 ms in response to a 5 ms decrement in A1A2 (Supplemental
Fig. S1A and B). Dual pathway AVN physiology could be identiﬁed in
both sham controls (19.6%) and LVD (33.3%) animals, with no signiﬁ-
cant difference between the two groups (Chi-square, p N 0.05).
3.4. Atrio-ventricular conduction assessed by optical mapping of activation
The effect of LVD on atrio-ventricular conductionwasmonitored op-
tically in a series of 4 sham and 4 LVD isolated AVN preparations loaded
with the voltage-sensitive dye RH237, to determine directly the site
showing the largest conduction slowing. Fig. 5 shows LVD effects on
mean activation time (Tact) measured from optically derived action po-
tentials. The data (Fig. 5) show that Tact is signiﬁcantly longer in the
compact AVN and His bundle regions in LVD versus controls (ANOVA
p b 0.001), with no signiﬁcant difference in Tact at the atrial and AVN
input regions, consistent with the observation that LVD has no effect
on intra-atrial conduction (see Langendorff-perfused hearts results).
Conduction times between regions (ΔTact) are shown in Fig. 5B. There
is signiﬁcant delay in conduction between the AVN input and compact
AVN region in LVD, compared to sham (62 ± 14 ms in LVD vs. 16 ±
5 ms, n= 4 each, p b 0.001).
3.5. Fibrosis and alterations in connexin expression
Immunohistochemistry and histology of tissue sections prepared
from isolated AVN preparations revealed the presence ofﬁbrosis, higher
Fig. 4. Electrical characteristics of the isolated AVN (ii). A: Examples of atrial and His bundle electrograms during a premature stimulation pacing protocol. In this example AVN
refractoriness is demonstrated by absence of the His bundle electrogram following the atrial signal (A2) from premature beat S2. AVN ERP is derived by plotting the A2H2 interval
against the corresponding A1A2 interval; AV N FRP is derived by plotting the H1H2 interval against the corresponding A1A2 interval. B: Graphs of atrial effective refractory period, and
AVN effective and functional refractory periods (in [ms]). Results expressed as mean ± SEM.
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pact AVN and atrio-nodal (AN) region of LVD animals compared to
sham (Table 1, Fig. 6, Fig. S2). Fibrosis increased in the AN region and
compact AVN (AN region: 20.8 ± 0.9% in LVD vs. 14.5 ± 0.9% of tissue
area in sham animals, n = 7 each, p = 0.0006; compact AVN: 37.9 ±
1.3% in LVD vs. 26.6 ± 0.5% of tissue area in sham animals, n= 7 each,
p= 0.0006), despite the fact that this tissue was distant from the (api-
cally located) post-MI scar. Non-myocyte to myocyte area ratio in-
creased signiﬁcantly in the AN region from 0.18 ± 0.01 in control to
0.26 ± 0.02 in LVD (p b 0.05; n = 7), and in the compact AVN from
0.55 ± 0.03 in control to 0.75 ± 0.06 in LVD (p b 0.05; n= 7; compare
panels on right to left in Fig. 6), indicating a net increase in non-myocyte
content. Quantitative assessment of overall connexinprotein showed an
increase in Cx43 density in the AN region and a decrease in Cx40 density
in both AN region and compact AVN in LVD rabbits compared to sham
(Table 1, Fig. 6).
Triple labelling for connexins, myocytes and non-myocytes allowed
connexin expression to be related to underlying cell types. Myocyte
Cx43 levels did not change in AN myocytes, but a signiﬁcant increase
in Cx43was observed in AN non-myocytes. Cx40 density decreased sig-
niﬁcantly within myocytes and non-myocytes in AN region and com-
pact AVN of LVD preparations compared to sham (Table 1; Fig. 6).
Relative non-myocyte/myocyte associated Cx40 expression remained
unchanged during LVD in AN tissue and compact node, while relative
Cx43 expression by non-myocyteswas signiﬁcantly increased in AN tis-
sue. A fraction of Cx43 and Cx40 was found to co-localize with both
myocytes andnon-myocytes, suggesting their presence at points of con-
tact between the two cell types in both the AN region and compact AVN.In LVD animals a signiﬁcant increase in myocyte–non-myocyte
heterocellular connexin localization was observed in the AN region
(Cx43: LVD = 11.1 ± 1.9% vs. sham = 2.2 ± 0.7% of total Cx43;
p b 0.005; Cx40: LVD = 6.7 ± 1.0% vs. sham = 3.7 ± 0.8% of total
Cx40; p b 0.05; Table 1).
4. Discussion
The present study provides ﬁrst evidence of AVN functional and
structural remodelling in a rabbit model of CHF, secondary to apical
MI. Despite the absence of a direct ischemic insult to the AVN, functional
and structural alterations, including increased atrio-ventricular conduc-
tion time, prolongation of refractory period, ﬁbrosis and alteration in
gap junction levels were observed in the AVN of LVD rabbits. This sug-
gests that AVN remodellingmay occur as a pathophysiological response
to MI irrespective of where the infarct scar is located.
Initially atrio-ventricular delay was assessed in vivo via surface ECG
studies. A signiﬁcant prolongation of the PQ interval by approximately
7 ms (10%) was observed in LVD animals, compared to sham controls.
Given that no signiﬁcant difference in heart rate was observed between
the two groups (Fig. 1C), PQ interval prolongation cannot be the result
of heart rate-related effects on conduction. The lack of effects on sino-
atrial node function was conﬁrmed via in vitro studies which demon-
strated no difference in the spontaneous sinus cycle length in LVD prep-
arations versus sham controls.
A potential contribution to the prolonged PQ interval could stem
from longer atrial conduction times, associated with enlarged atria
post-MI. Echo based assessment of left atrial dimension (including
Fig. 5. Regional activation time (Tact) measured from optical mapping recordings in isolated AVN preparations. A: Panel (i), CCD image of an isolated AVN preparation, the areas shown
correspond to: Region 1: atrium to AVN input; Region 2: AVN input to compact node; Region 3: compact node to His bundle. Panel (ii): isochronal maps of activation showing
conduction slowing at region 2 and region 3 in LVD compared to control. B: Time to activation (Tact) relative to the atrial electrogram in sham and LVD preparations, and conduction
times between adjacent regions (ΔTact). There is signiﬁcant prolongation of Tact in LVD at the compact node and His bundle regions compared to controls (ANOVA p b 0.001). This is
predominantly a consequence of signiﬁcant delay in conduction between the AVN input and compact node region. *p b 0.001. n= 4 sham control/4 LVD.
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chamber volume) as previously reported in this model [22]. Previous
work has reported no change in atrial conduction velocity in the rabbit
LVD model [37] which was estimated at approximately 50 cm/s. Based
on these measurements, and even allowing for a sino-atrial node to
AVN distance of 50% of themaximum atrial circumference, the enlargedatria would cause only a 2–3 ms increase in delay between sino-atrial
node and AVN conduction time i.e. considerably less than the additional
delay measured in vivo (7–8 ms).
Further evidence supporting the presence of abnormal conduction
inside the AVN in the LVD model comes from intact heart optical map-
ping studies (Fig. 2). The time to earliest LV epicardial activation during
Table 1
Cx43 and Cx40 density in the atrio-nodal region and compact AVN of LVD and sham hearts.
Atrio-nodal region Compact AVN
Cx43 Cx40 Cx40
Sham n= 7 LVD n= 7 Sham n= 7 LVD n= 7 Sham n= 7 LVD n= 7
Area × 10−2 μm2 × μm−2 Cx 1.30 ± 0.07 1.54 ± 0.06⁎ 11.65 ± 1.5‡ 4.69 ± 0.69⁎⁎‡ 13.61 ± 0.97 6.24 ± 0.57⁎⁎
M Cx 1.46 ± 0.08 1.59 ± 0.03 12.80 ± 1.56‡ 5.39 ± 0.79⁎⁎‡ 18.98 ± 1.14Ψ 9.73 ± 1.13⁎⁎ΨΨ
nM Cx 0.52 ± 0.10 1.40 ± 0.22⁎⁎ 5.02 ± 0.73‡ 2.05 ± 0.27⁎ 3.63 ± 0.69 1.37 ± 0.28⁎⁎Ψ
nM/M 0.34 ± 0.07 0.85 ± 0.13⁎ 0.36 ± 0.03 0.38 ± 0.02‡ 0.18 ± 0.03ΨΨ 0.16 ± 0.02ΨΨ
M-nM Cx(%) 2.18 ± 0.69 11.08 ± 1.91⁎⁎ 3.68 ± 0.80 6.73 ± 0.99⁎ 7.17 ± 1.19Ψ 8.91 ± 0.85
Data obtained from sham and 8 weeks LVD hearts were compared using unpaired t-test. Connexin (Cx) density is expressed as area of connexin-related ﬂuorescence per total tissue area
(μm2 × μm−2; Cx) or cell type-speciﬁc tissue area (M Cx, nM Cx), and as the ratio of nM/M. M-nM Cx (%)= % of connexin expressed by both myocytes and non-myocytes relative to the
total connexin area. Data are presented as mean ± S.E.M. n= 7 sham and 7 LVD AVN preparations. ⁎p b 0.05 and ⁎⁎p b 0.005 vs. sham (statistically signiﬁcant differences).
Cx40 in compact AVN vs. atrio-nodal region and atrio-nodal levels of Cx40 vs. Cx43 were compared using unpaired t-test. Ψp b 0.05 and ΨΨp b 0.005 vs. Cx40 in atrio-nodal region.
‡p b 0.001 vs. Cx43 in atrio-nodal region. M: myocytes. nM: non-myocytes.
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trols by approximately 14 ms (16%) (Fig. 2C and D), and this time pro-
gressively increased with faster pacing rates (Fig. 2D), characteristic of
decremental conduction properties of the AVN. Epicardial activation
time was mapped at corresponding sites of healthy and LVD hearts
(Fig. 2C), and proximal to the apical MI scar region. Therefore, delayed
conduction into or near the scarwas not themechanism of the observed
delay.
Furthermore, therewas no signiﬁcant effect on intra-atrial and intra-
ventricular conduction, suggesting that an abnormally slow propaga-
tion through the AVN is the basis of the delayed LV activation timing
in intact hearts with LVD. This was conﬁrmed by measurements fromFig. 6. Triple immunolabelling for myocytes (M; red: anti-myomesin antibody), non-myocytes
(green) in sham and LVD rabbit AVNpreparations. Different arrow styles indicate Cx colocalizati
M-F). Small panels show 2.5 × zoomed views of the areas highlighted by dashed squares in th
compact AVN of LVD animals vs. sham, and increased non-myocyte content.isolated AVN preparations in which the conduction time wasmeasured
directly via surface electrograms.
Atrio-ventricular conduction was assessed in isolated AVN prepara-
tions containing the Triangle of Koch by applying pacing protocols to
create atrio-ventricular conduction and refractory curves (Figs. 3 and
4). The results indicate the presence of electrical remodelling in the
AVN of LVD rabbits. This manifested as prolongation of the time taken
for excitation to propagate between the atrium and the bundle of His
(AH interval) at all tested pacing cycle lengths by approximately
15 ms in the LVD group (Fig. 3C). Furthermore, a prolongation of the
Wenckebach cycle length by approximately 40 ms was observed in
LVD animals compared to sham controls (Fig. 3C). The atrio-(based on shape and distribution, ﬁbroblasts: F; blue: anti-vimentin antibody), and Cx40
onwithmyocytes only (↓:M), non-myocytes only (←: F), or at heterotypic cell contacts (➚:
e main images. Scale bars: 30 μm. Note reduction in Cx40 levels in atrio-nodal region and
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increase in effective and functional refractory periods of the AVN in
the absence of change in atrial refractoriness (Fig. 4).
Given the anatomical complexity and heterogeneity of the AVN, the
mechanisms by which conduction velocity through the AVN is reduced
by LVD are likely to be multiple and complex. In this study, functional
measurements of atrio-ventricular conduction in LVD rabbits have
shown an increased atrio-ventricular conduction delay by approxi-
mately 20% above the normal value, with prolongation of AVN refrac-
tory periods by approximately 35 ms. This could be indicative of a
disturbance of the electrotonic interaction of cells comprising the AVN,
and would have detrimental effects on atrio-ventricular coordination,
in particular at high heart rates.
There is considerable diversity in connexin expression within the
AVN and adjacent tissue areas, which is thought to be relevant for the
heart's complex conduction characteristics [13,38,39]. Studies of Cx40-
deﬁcient mice have found evidence of abnormal atrio-ventricular acti-
vationdelays [40,41]. Another study suggested a linkbetween heart fail-
ure and atrio-ventricular conduction defects as a result of alterations in
connexin expression in a transgenicmousemodel [42]. PR prolongation,
observed at 2 weeks of age rapidly progressed into complete AVN block
as early as 4 weeks of age. Expression of Cx40 and Cx43 was dramati-
cally decreased in the transgenic heart, which may have contributed
to the conduction defects in the transgenic mice. Separately, both ﬁbro-
sis and connexin down-regulation have been linked to conduction
slowing [43,44].
Whether the distribution of gap junctionswithin the AVN is affected
byMI has remained unclear.We therefore explored the hypothesis that
in the LVD rabbit model, MI and subsequent heart failure give rise to al-
tered connexin expression in the AVN, which could explain the abnor-
mal atrio-ventricular activation delay observed. Consistent with earlier
reports [27,45–47], gap junctions were not limited to myocytes but
are also expressed by non-myocytes (Fig. 6). At 8 weeks post-MI,
there was notable ﬁbrosis within the AN region and compact AVN of
LVD hearts (Fig. 6, Fig. S2). The increased ﬁbrosis within the AN region
is accompanied by increased density of Cx43 expression in non-
myocytes, but not myocytes. In contrast, Cx40 density was reduced in
myocytes of AN and compact AVN tissue in the LVD group (Table 1),
which may explain the prolongation of atrio-ventricular conduction in
the CHF model.
A fraction of connexinswas co-localizedwithﬂuorescence indicative
of both myocytes and non-myocytes in AN and compact AVN tissue,
suggesting the possible presence of heterocellular electrical connec-
tions. These were signiﬁcantly increased in LVD hearts, and, by increas-
ing electrotonic load, could contribute to conduction slowing in theAVN
[48,49].
However, the presence of connexin immunostaining at points of
contacts between two cell types is not proof of functional coupling,
and the possible contribution of heterocellular electrotonic coupling to
the functional observation in this model requires further investigations.
In a recent study using a rabbit model of cardiac hypertrophy induced
by aortic banding and aortic valve damage [11], structural and molecu-
lar (mRNA) changes were reported to occur in the AVN. This suggests
that remodelling of the electrophysiology of the AVN in response to
pathological interventions may involve changes in cellular electrophys-
iology alongside the changes reported here.
5. Conclusion
This study provides novel evidence to support the hypothesis that
prolongation of the PQ interval in a rabbit LVD model is due to remod-
elling of the AVN in response to remote MI. In the presence of a discrete
apical infarct, there was increased AVN ﬁbrosis, connexin remodelling,
prolongation of atrio-ventricular conduction, as well as of AVN effective
and functional refractory periods. The observed reduction in Cx40 ex-
pression and alterations in distribution and density of homo- andhetero-cellular Cx43/Cx40 protein in the AVN may provide a clue to
the mechanism of the abnormal delay. Further research is required to
pinpoint the dynamic changes in AVN electrophysiology.
6. Limitations
Our immunohistochemical analysiswas limited to two connexin iso-
forms, Cx43 and Cx40. Remodelling of the low-conductivity Cx45 iso-
form, also present in the AVN, could further contribute to the atrio-
ventricular conduction delay observed in this study. Unfortunately we
were unable to obtain reliable Cx45 staining for quantiﬁcation, using
currently available commercial Cx45 antibodies. Future studies involv-
ing genetic manipulation and/or labelling of connexins may hold the
key to a fuller understanding of the contribution of the individual
connexin isoform to AVN function and dysfunction.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.yjmcc.2016.03.011.
Disclosures
None.
Acknowledgements
Financially supported by the British Heart Foundation (FS/05/010/
18435 and FS/02/018/13463) and the European Research Council
(AdGCardioNECT). PC acknowledges support from theUK Physiological
Society.
References
[1] C. Alonso, C. Leclercq, F. Victor, H. Mansour, C. de Place, D. Pavin, et al., Electrocardio-
graphic predictive factors of long-term clinical improvement with multisite
biventricular pacing in advanced heart failure, Am. J. Cardiol. 84 (1999) 1417–1421.
[2] D.M. Gilligan, D. Sargent, V. Ponnathpur, D. Dan, J.S. Zakaib, K.A. Ellenbogen, Echo-
cardiographic atrioventricular interval optimization in patients with dual-chamber
pacemakers and symptomatic left ventricular systolic dysfunction, Am. J. Cardiol.
91 (2003) 629–631.
[3] R. Schoeller, D. Andresen, P. Buttner, K. Oezcelik, G. Vey, R. Schroder, First- or
second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomy-
opathy, Am. J. Cardiol. 71 (1993) 720–726.
[4] W. Shamim, D.P. Francis, M. Yousufuddin, S. Varney, M.F. Pieopli, S.D. Anker, et al.,
Intraventricular conduction delay: a prognostic marker in chronic heart failure,
Int. J. Cardiol. 70 (1999) 171–178.
[5] W. Shamim, M. Yousufuddin, M. Cicoria, D.G. Gibson, A.J. Coats, M.Y. Henein, Incre-
mental changes in QRS duration in serial ECGs over time identify high risk elderly
patients with heart failure, Heart 88 (2002) 47–51.
[6] W.T. Abraham, Rationale and design of a randomized clinical trial to assess the
safety and efﬁcacy of cardiac resynchronization therapy in patients with advanced
heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE), J.
Card. Fail. 6 (2000) 369–380.
[7] W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, E. Loh, et al., Cardiac
resynchronization in chronic heart failure, N. Engl. J. Med. 346 (2002) 1845–1853.
[8] D.J. Bradley, E.A. Bradley, K.L. Baughman, R.D. Berger, H. Calkins, S.N. Goodman, et al.,
Cardiac resynchronization and death from progressive heart failure: a meta-analysis
of randomized controlled trials, JAMA 289 (2003) 730–740.
[9] M. Gasparini, M. Mantica, P. Galimberti, U. La Marchesina, M. Manglavacchi, F.
Faletra, et al., Optimization of cardiac resynchronization therapy: technical aspects,
Eur. Heart J. Suppl. 4 (D82–D7) (2002).
[10] Z.I. Whinnett, J.E. Davies, K. Willson, C.H. Manisty, A.W. Chow, R.A. Foale, et al., Hae-
modynamic effects of changes in atrioventricular and interventricular delay in car-
diac resynchronisation therapy show a consistent pattern: analysis of shape,
magnitude and relative importance of atrioventricular and interventricular delay,
Heart 92 (2006) 1628–1634.
[11] T. Nikolaidou, X.J. Cai, R.S. Stephenson, J. Yanni, T. Lowe, A.J. Atkinson, et al., Conges-
tive heart failure leads to prolongation of the PR interval and atrioventricular junc-
tion enlargement and ion channel remodelling in the rabbit, PLoS One 10 (2015),
e0141452.
[12] H. Dobrzynski, R.H. Anderson, A. Atkinson, Z. Borbas, A. D'Souza, J.F. Fraser, et al.,
Structure, function and clinical relevance of the cardiac conduction system, includ-
ing the atrioventricular ring and outﬂow tract tissues, Pharmacol. Ther. 139
(2013) 260–288.
[13] I.P. Temple, S. Inada, H. Dobrzynski, M.R. Boyett, Connexins and the atrioventricular
node, Heart Rhythm. 10 (2013) 297–304.
[14] T.N. Mazgalev, D.R. Van Wagoner, I.R. Eﬁmov, Mechanisms of AV nodal excitability
and propagation, Cardiac Electrophysiology: From Cell to Bedside, W.B. Saunders
Co. 1999, pp. 196–205 Zipes & Jalife.
64 A.M. Nisbet et al. / Journal of Molecular and Cellular Cardiology 94 (2016) 54–64[15] T.N. James, Structure and function of the sinus node, AV node and his bundle of the
human heart: part II–function, Prog. Cardiovasc. Dis. 45 (2003) 327–360.
[16] J. Merideth, C. Mendez, W.J. Mueller, G.K. Moe, Electrical excitability of atrioventric-
ular nodal cells, Circ. Res. 23 (1968) 69–85.
[17] J. Billette, S. Nattel, Dynamic behavior of the atrioventricular node: a functional
model of interaction between recovery, facilitation, and fatigue, J. Cardiovasc.
Electrophysiol. 5 (1994) 90–102.
[18] F.L. Burton, A.R. McPhaden, S.M. Cobbe, Ventricular ﬁbrillation threshold and local
dispersion of refractoriness in isolated rabbit hearts with left ventricular dysfunc-
tion, Basic Res. Cardiol. 95 (2000) 359–367.
[19] S.E. Litwin, J.H. Bridge, Enhanced Na+-Ca2+ exchange in the infarcted heart. Impli-
cations for excitation-contraction coupling, Circ. Res. 81 (1997) 1083–1093.
[20] K.W. Mahaffey, T.E. Raya, G.D. Pennock, E. Morkin, S. Goldman, Left ventricular per-
formance and remodeling in rabbits after myocardial infarction. Effects of a thyroid
hormone analogue, Circulation 91 (1995) 794–801.
[21] M.A. McIntosh, S.M. Cobbe, G.L. Smith, Heterogeneous changes in action potential
and intracellular Ca2+ in left ventricular myocyte sub-types from rabbits with
heart failure, Cardiovasc. Res. 45 (2000) 397–409.
[22] G.A. Ng, S.M. Cobbe, G.L. Smith, Non-uniform prolongation of intracellular Ca2+
transients recorded from the epicardial surface of isolated hearts from rabbits
with heart failure, Cardiovasc. Res. 37 (1998) 489–502.
[23] M.P. Pye, S.M. Cobbe, Arrhythmogenesis in experimentalmodels of heart failure: the
role of increased load, Cardiovasc. Res. 32 (1996) 248–257.
[24] M.P. Pye, M. Black, S.M. Cobbe, Comparison of in vivo and in vitro haemodynamic
function in experimental heart failure: use of echocardiography, Cardiovasc. Res.
31 (1996) 873–881.
[25] S.F. Mironov, F.J. Vetter, A.M. Pertsov, Fluorescence imaging of cardiac propagation:
spectral properties and ﬁltering of optical action potentials, Am. J. Physiol. Heart
Circ. Physiol. 291 (2006) H327–H335.
[26] N.L. Walker, F.L. Burton, S. Kettlewell, G.L. Smith, S.M. Cobbe, Mapping of epicardial
activation in a rabbit model of chronic myocardial infarction, J. Cardiovasc.
Electrophysiol. 18 (2007) 862–868.
[27] P. Camelliti, C.R. Green, I. LeGrice, P. Kohl, Fibroblast network in rabbit sinoatrial
node: structural and functional identiﬁcation of homogeneous and heterogeneous
cell coupling, Circ. Res. 94 (2004) 828–835.
[28] P. Camelliti, S.A. Al-Saud, R.T. Smolenski, S. Al-Ayoubi, A. Bussek, E. Wettwer, et al.,
Adult human heart slices are a multicellular system suitable for electrophysiological
and pharmacological studies, J. Mol. Cell. Cardiol. 51 (2011) 390–398.
[29] R.C. Myles, F.L. Burton, S.M. Cobbe, G.L. Smith, Alternans of action potential duration
and amplitude in rabbits with left ventricular dysfunction following myocardial in-
farction, J. Mol. Cell. Cardiol. 50 (2011) 510–521.
[30] F.R. Quinn, S. Currie, A.M. Duncan, S. Miller, R. Sayeed, S.M. Cobbe, et al., Myocardial
infarction causes increased expression but decreased activity of the myocardial
Na+-Ca2+ exchanger in the rabbit, J. Physiol. 553 (2003) 229–242.
[31] G.A. Ng, M.N. Hicks, S.M. Cobbe, G.L. Smith, Depressed inotropic response to in-
creased preload in rabbit hearts with left-ventricular dysfunction induced by
chronic myocardial infarction, Pﬂugers Arch. 444 (2002) 513–522.[32] P. Neary, A.M. Duncan, S.M. Cobbe, G.L. Smith, Assessment of sarcoplasmic reticulum
Ca2+ ﬂux pathways in cardiomyocytes from rabbits with infarct-induced left-
ventricular dysfunction, Pﬂugers Arch. 444 (2002) 360–371.
[33] P. Neary, S.M. Cobbe, G.L. Smith, Reduced sarcoplasmic reticulum Ca2+ release in
rabbits with left ventricular dysfunction, Ann. N. Y. Acad. Sci. 853 (1998) 338–340.
[34] C. Mendez, G.K. Moe, Demonstration of a dual A-V nodal conduction system in the
isolated rabbit heart, Circ. Res. 19 (1966) 378–393.
[35] V. Nikolski, I. Eﬁmov, Fluorescent imaging of a dual-pathway atrioventricular-nodal
conduction system, Circ. Res. 88 (2001) E23–E30.
[36] V.P. Nikolski, S.A. Jones, M.K. Lancaster, M.R. Boyett, I.R. Eﬁmov, Cx43 and dual-
pathway electrophysiology of the atrioventricular node and atrioventricular nodal
reentry, Circ. Res. 92 (2003) 469–475.
[37] S. Kettlewell, F.L. Burton, G.L. Smith, A.J. Workman, Chronic myocardial infarction
promotes atrial action potential alternans, afterdepolarizations, and ﬁbrillation,
Cardiovasc. Res. 99 (2013) 215–224.
[38] S.R. Coppen, N.J. Severs, Diversity of connexin expression patterns in the atrioven-
tricular node: vestigial consequence or functional specialization? J. Cardiovasc.
Electrophysiol. 13 (2002) 625–626.
[39] H. Dobrzynski, V.P. Nikolski, A.T. Sambelashvili, I.D. Greener, M. Yamamoto, M.R.
Boyett, et al., Site of origin and molecular substrate of atrioventricular junctional
rhythm in the rabbit heart, Circ. Res. 93 (2003) 1102–1110.
[40] A.M. Simon, D.A. Goodenough, D.L. Paul, Mice lacking connexin40 have cardiac con-
duction abnormalities characteristic of atrioventricular block and bundle branch
block, Curr. Biol. 8 (1998) 295–298.
[41] W. Zhu, S. Saba,M.S. Link, E. Bak, M.K. Homoud, N.A. Estes 3rd, et al., Atrioventricular
nodal reverse facilitation in connexin40-deﬁcient mice, Heart Rhythm. 2 (2005)
1231–1237.
[42] H. Kasahara, H. Wakimoto, M. Liu, C.T. Maguire, K.L. Converso, T. Shioi, et al., Pro-
gressive atrioventricular conduction defects and heart failure in mice expressing a
mutant Csx/Nkx2.5 homeoprotein, J. Clin. Invest. 108 (2001) 189–201.
[43] Y. Xie, A. Garﬁnkel, P. Camelliti, P. Kohl, J.N. Weiss, Z. Qu, Effects of ﬁbroblast-
myocyte coupling on cardiac conduction and vulnerability to reentry: a computa-
tional study, Heart Rhythm. 6 (2009) 1641–1649.
[44] R.M. Shaw, Y. Rudy, Ionic mechanisms of propagation in cardiac tissue. Roles of the
sodium and L-type calcium currents during reduced excitability and decreased gap
junction coupling, Circ. Res. 81 (1997) 727–741.
[45] P. Camelliti, G.P. Devlin, K.G. Matthews, P. Kohl, C.R. Green, Spatially and temporally
distinct expression of ﬁbroblast connexins after sheep ventricular infarction,
Cardiovasc. Res. 62 (2004) 415–425.
[46] E.C. Goldsmith, A. Hoffman, M.O. Morales, J.D. Potts, R.L. Price, A. McFadden, et al.,
Organization of ﬁbroblasts in the heart, Dev. Dyn. 230 (2004) 787–794.
[47] P. Camelliti, C.R. Green, P. Kohl, Structural and functional coupling of cardiac
myocytes and ﬁbroblasts, Adv. Cardiol. 42 (2006) 132–149.
[48] P. Kohl, P. Camelliti, Fibroblast-myocyte connections in the heart, Heart Rhythm. 9
(2012) 461–464.
[49] P. Kohl, R.G. Gourdie, Fibroblast-myocyte electrotonic coupling: does it occur in na-
tive cardiac tissue? J. Mol. Cell. Cardiol. 70 (2014) 37–46.
